Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia.

about

Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia.

Item

http://www.wikidata.org/entity/Q42524512

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Vancomycin monotherapy vs. com ...... phylococcus aureus bacteremia.

@en

Vancomycin monotherapy vs. com ...... phylococcus aureus bacteremia.

@nl

type

Item

label

Vancomycin monotherapy vs. com ...... phylococcus aureus bacteremia.

@en

Vancomycin monotherapy vs. com ...... phylococcus aureus bacteremia.

@nl

prefLabel

Vancomycin monotherapy vs. com ...... phylococcus aureus bacteremia.

@en

Vancomycin monotherapy vs. com ...... phylococcus aureus bacteremia.

@nl

P1476

Vancomycin monotherapy vs. com ...... phylococcus aureus bacteremia.

@en

P2093

Christine B Teng

http://www.w3.org/2001/XMLSchema#string

Jonathan Seah

http://www.w3.org/2001/XMLSchema#string

Prabha Krishnan

http://www.w3.org/2001/XMLSchema#string

Saugata Choudhury

http://www.w3.org/2001/XMLSchema#string

Tat-Ming Ng

http://www.w3.org/2001/XMLSchema#string

P2860

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains.

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method

Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes.

The management of Staphylococcus aureus bacteremia in the United Kingdom and Vietnam: a multi-centre evaluation.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Evaluation of a direct blood culture disk diffusion antimicrobial susceptibility test

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.

Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore.

The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

P304

734-739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/VIRU.26909

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David C. Lye

P577

2013-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258115589

http://www.w3.org/2001/XMLSchema#string

P698

24165210

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus

P932

3925706

http://www.w3.org/2001/XMLSchema#string